Experimental evidence for the age dependence of tau protein spread in the brain.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
06 2019
Historique:
received: 11 01 2019
accepted: 16 05 2019
entrez: 29 6 2019
pubmed: 30 6 2019
medline: 1 5 2020
Statut: epublish

Résumé

The incidence of Alzheimer's disease (AD), which is characterized by progressive cognitive decline that correlates with the spread of tau protein aggregation in the cortical mantle, is strongly age-related. It could be that age predisposes the brain for tau misfolding and supports the propagation of tau pathology. We tested this hypothesis using an experimental setup that allowed for exploration of age-related factors of tau spread and regional vulnerability. We virally expressed human tau locally in entorhinal cortex (EC) neurons of young or old mice and monitored the cell-to-cell tau protein spread by immunolabeling. Old animals showed more tau spreading in the hippocampus and adjacent cortical areas and accumulated more misfolded tau in EC neurons. No misfolding, at any age, was observed in the striatum, a brain region mostly unaffected by tangles. Age and brain region dependent tau spreading and misfolding likely contribute to the profound age-related risk for sporadic AD.

Identifiants

pubmed: 31249873
doi: 10.1126/sciadv.aaw6404
pii: aaw6404
pmc: PMC6594764
doi:

Substances chimiques

tau Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eaaw6404

Subventions

Organisme : NINDS NIH HHS
ID : T32 NS048005
Pays : United States

Références

Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):721-6
pubmed: 12522269
PLoS One. 2012;7(2):e31302
pubmed: 22312444
Neurobiol Aging. 1995 May-Jun;16(3):271-8; discussion 278-84
pubmed: 7566337
Front Aging Neurosci. 2017 Sep 27;9:311
pubmed: 29021756
Acta Neuropathol Commun. 2014 Jan 30;2:14
pubmed: 24479894
PLoS One. 2013 Nov 20;8(11):e80834
pubmed: 24278327
Elife. 2018 Jul 10;7:
pubmed: 29988016
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):251-9
pubmed: 15615643
Neuron. 2012 Feb 23;73(4):685-97
pubmed: 22365544
Cereb Cortex. 1991 Jan-Feb;1(1):103-16
pubmed: 1822725
Nat Neurosci. 2014 Mar;17(3):357-66
pubmed: 24464041
Acta Neuropathol. 2014 May;127(5):667-83
pubmed: 24531916
J Exp Med. 2016 Nov 14;213(12):2635-2654
pubmed: 27810929
Nat Biotechnol. 2004 May;22(5):589-94
pubmed: 15064769
Front Neurosci. 2017 Apr 06;11:185
pubmed: 28428740
Mol Neurodegener. 2017 Jun 29;12(1):50
pubmed: 28662669
Alzheimers Dement. 2016 Apr;12(4):459-509
pubmed: 27570871
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4376-85
pubmed: 25261551
Cell Rep. 2018 Mar 27;22(13):3612-3624
pubmed: 29590627
Nat Neurosci. 2015 Nov;18(11):1584-93
pubmed: 26436904
Nat Cell Biol. 2009 Jul;11(7):909-13
pubmed: 19503072
Transl Neurosci. 2015 Oct 23;6(1):214-226
pubmed: 28123806
Acta Neuropathol. 2015 Sep;130(3):349-62
pubmed: 26150341
J Biol Chem. 2001 Dec 21;276(51):48165-74
pubmed: 11606569
J Biol Chem. 1996 Dec 20;271(51):32789-95
pubmed: 8955115
Cell Rep. 2018 May 15;23(7):2039-2055
pubmed: 29768203
Sci Rep. 2015 Jun 09;5:11161
pubmed: 26057852
Nat Neurosci. 2019 Jan;22(1):57-64
pubmed: 30559471
Glia. 2017 Aug;65(8):1302-1316
pubmed: 28519902
J Exp Med. 2018 Sep 3;215(9):2355-2377
pubmed: 30108137
Methods Cell Biol. 2017;141:307-322
pubmed: 28882310
Neurology. 1992 Mar;42(3 Pt 1):631-9
pubmed: 1549228
EMBO J. 2015 Dec 14;34(24):3028-41
pubmed: 26538322
Prog Brain Res. 2014;214:207-27
pubmed: 25410360
J Neurosci. 2013 Jan 16;33(3):1024-37
pubmed: 23325240
Aging Cell. 2012 Aug;11(4):628-33
pubmed: 22510449
Nat Neurosci. 2016 Aug;19(8):1085-92
pubmed: 27322420

Auteurs

Susanne Wegmann (S)

German Center for Neurodegenerative Diseases (DZNE), 10117 Berlin, Germany.
Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Rachel E Bennett (RE)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Louis Delorme (L)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Ashley B Robbins (AB)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Miwei Hu (M)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Danny McKenzie (D)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Molly J Kirk (MJ)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Julia Schiantarelli (J)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Nahel Tunio (N)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Ana C Amaral (AC)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Zhanyun Fan (Z)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Samantha Nicholls (S)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Eloise Hudry (E)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Bradley T Hyman (BT)

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH